Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+20.9%
5Y CAGR+17.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+20.9%/yr
vs +22.0%/yr prior
5Y CAGR
+17.7%/yr
Recent acceleration
Acceleration
-1.1pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $40.78M | -2.4% |
| 2024 | $41.79M | +27.5% |
| 2023 | $32.76M | +41.9% |
| 2022 | $23.09M | +35.2% |
| 2021 | $17.07M | -5.4% |
| 2020 | $18.05M | +35.6% |
| 2019 | $13.31M | +27.9% |
| 2018 | $10.41M | +49.7% |
| 2017 | $6.95M | +142.1% |
| 2016 | $2.87M | - |